Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,863
Sort by:
2019-2023 Europe Cancer Diagnostics Market Analysis: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation
US$ 19,700.00
... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
January 2019
820 pages
Blood Cancer Therapeutics: Global Markets to 2023
US$ 1,375.00
... , reimbursement and patents. It analyzes prevailing blood cancer treatment guidelines in different geographic regions. The scope of the blood cancer therapeutic market is restricted to three disease areas: leukemia ...
December 2018
174 pages
Colorectal Cancer - Pipeline Review, H2 2018
US$ 2,500.00
... releases. The Colorectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2018
2548 pages
Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions
US$ 1,375.00
... “Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions” presents qualitative and quantitative information on the current market dynamics ... overview of global cancer therapeutics market with special focus on recurrent and metastatic divisions Country specific data and analysis for US, ...
December 2018
288 pages
Asia Pacific Cancer Immunotherapy Market (2018 - 2024)
US$ 1,500.00
... Asia Pacific Market would witness market growth of 16.5% CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer ...
December 2018
86 pages
Europe Cancer Immunotherapy Market (2018 - 2024)
US$ 1,500.00
The Europe Cancer Immunotherapy Market would witness market growth of 13.5 % CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There ...
December 2018
86 pages
Global Cancer Immunotherapy Market (2018 - 2024)
US$ 3,600.00
... from different types of cancer such as lung cancer, breast cancer, ovarian cancer, and other cancers are the factors that drive the global cancer immunotherapy market. Additionally, growing geriatric ...
December 2018
229 pages
North America Cancer Immunotherapy Market (2018 - 2024)
US$ 1,500.00
... North America Cancer Immunotherapy Market would witness market growth of 13.1% CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer ...
December 2018
77 pages
Cancer Pain Market by Drug Type (Opioids, Non-Opioids, and Nerve Blockers) and Disease Indication (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
US$ 4,296.00
... of cancer pain drugs further drive the market growth. However, adverse effects associated with cancer pain are projected to impede the market growth. The global cancer pain market is segmented based on drug ...
December 2018
177 pages
